Bringing the fundamentals into focus…
Back to Teva Pharmaceutical Industries Limited
How Teva Pharmaceutical Industries Limited stacks up
TEVA · against 61 other Healthcare companies of similar size
Profitability
80/ 100
Above the middle of the pack.
Ranked #30 of 62 · scores higher than 51% of peers
Bars: peers in each 10-point band of the profitability score13 peers with a profitability score of 80–89, including TEVA · Click a bar to see the companies
Why profitability scores 80?
Weighted metrics compared with all Healthcare companies.Mainly thanks to its return on invested capital, which is stronger than most Healthcare peers.
- Return on assets is close to the peer norm. Return on assets: 1.8% vs peer median 1.7%
- Operating margin is close to the peer norm. Operating margin: 9.3% vs peer median 7.1%
- a higher return on invested capital: stronger than 93% of peers. Return on invested capital: 30.9% vs peer median 4.7%
Metric by metric
Position: dot = TEVA, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | TEVA | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Return on invested capitalHigher is better · 58 reported | 30.9% | 11.5% | 82% | 33% | |
| Operating marginHigher is better · 60 reported | 9.3% | 20.1% | 22% | 33% | |
| Return on assetsHigher is better · 60 reported | 1.8% | 5.9% | 12% | 33% | |
| Return on equityHigher is better · 57 reported | 9.7% | 14.0% | 32% | Context only | |
| Gross marginHigher is better · 62 reported | 52.5% | 59.5% | 36% | Context only |
Ranking by profitability score
Top 5 and the companies ranked around TEVA| Rank | Company | Market cap | Profitability | Overall |
|---|---|---|---|---|
| 1 | 11.26T JPY (≈$76.6B) | 99 | 72 | |
| 1 | 52.9B USD | 99 | 57 | |
| 3 | 8.24T JPY (≈$56.0B) | 98 | 75 | |
| 4 | 193.6B HKD (≈$24.8B) | 97 | 78 | |
| 4 | 31.3B USD | 97 | 63 | |
| 27 | 43.30T KRW (≈$31.2B) | 84 | 68 | |
| 28 | 54.9B USD | 83 | 59 | |
| 29 | 6.17T JPY (≈$42.0B) | 81 | 70 | |
| 30 | 38.4B USD | 80 | 50 | |
| 30 | 48.9B USD | 80 | 54 | |
| 32 | 63.0B USD | 79 | 65 | |
| 32 | 540.4B BRL (≈$97.3B) | 79 | 64 | |
| 34 | 45.9B USD | 78 | 61 | |
| 35 | 95.4B AUD (≈$62.9B) | 77 | 48 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score